Quantcast Biocryst Partner Seeks Peramivir Approval In Japan - Congoo
 
 
JOB MARKETS Log In
BioCryst Partner Seeks Peramivir Approval in Japan
Have an interest in this Story?
Sign Up for Real-Time email updates
ABC News  | November 04, 2009

BioCryst Pharmaceuticals Inc. said Wednesday its partner Shionogi & Co. filed for approval to market BioCryst's IV flu drug peramivir in Japan. Shionogi's filing triggers a $7 million milestone payment to BioCryst. Peramivir is an intravenous drug intended to treat the flu in patients who are hospit...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Matthew Clark Matthew Clark
Mentor
Entrepreneur
David Hood David Hood
Director
Marketing/Public Relations

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.